Skip to content
10-Q

Quarterly Report

Syndax Pharmaceuticals, Inc. SNDX

0001193125-25-262521

← back to feed
Filed
Nov 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 86.91M sh
Shares Diluted Q3 2025 · Sep 30, 2025 86.62M sh
Shares Diluted Q3 2025 · Sep 30, 2025 86.53M sh
Shares Diluted Q3 2025 · Sep 30, 2024 85.43M sh
Shares Diluted Q3 2025 · Sep 30, 2024 85.31M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$253.49M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$217.52M
Short Term Debt Q3 2025 · Sep 30, 2025 $343.91M
Short Term Debt Q3 2025 · Dec 31, 2024 $343.68M
Short Term Investments Q3 2025 · Sep 30, 2025 $319.17M
Short Term Investments Q3 2025 · Dec 31, 2024 $418.8M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $116.81M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $154.08M
Stockholders Equity Q3 2025 · Sep 30, 2025 $115.43M
Stockholders Equity Q3 2025 · Jun 30, 2025 $157.42M
Stockholders Equity Q3 2025 · Mar 31, 2025 $215.06M
Stockholders Equity Q3 2025 · Dec 31, 2024 $288.12M
Stockholders Equity Q3 2025 · Sep 30, 2024 $366.43M
Stockholders Equity Q3 2025 · Jun 30, 2024 $434.34M
Stockholders Equity Q3 2025 · Mar 31, 2024 $491.89M
Stockholders Equity Q3 2025 · Dec 31, 2023 $554.2M
Current Liabilities Q3 2025 · Sep 30, 2025 $114.19M
Current Liabilities Q3 2025 · Dec 31, 2024 $103.55M
Total Liabilities Q3 2025 · Sep 30, 2025 $436.36M
Total Liabilities Q3 2025 · Dec 31, 2024 $436.69M
Current Assets Q3 2025 · Sep 30, 2025 $529.83M
Current Assets Q3 2025 · Dec 31, 2024 $603.06M
Total Assets Q3 2025 · Sep 30, 2025 $551.79M
Total Assets Q3 2025 · Dec 31, 2024 $724.82M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.70
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.51
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.98
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.63
Eps Basic Q3 2025 · Sep 30, 2025 −$0.70
Eps Basic Q3 2025 · Sep 30, 2025 −$2.51
Eps Basic Q3 2025 · Sep 30, 2024 −$0.98
Eps Basic Q3 2025 · Sep 30, 2024 −$2.63
Rd Expense Q3 2025 · Sep 30, 2025 $56.28M
Rd Expense Q3 2025 · Sep 30, 2025 $180.14M
Rd Expense Q3 2025 · Sep 30, 2024 $70.97M
Rd Expense Q3 2025 · Sep 30, 2024 $176.12M
Net Income Q3 2025 · Sep 30, 2025 −$60.72M
Net Income Q3 2025 · Sep 30, 2025 −$217.41M
Net Income Q3 2025 · Jun 30, 2025 −$71.85M
Net Income Q3 2025 · Mar 31, 2025 −$84.85M
Net Income Q3 2025 · Sep 30, 2024 −$84.13M
Net Income Q3 2025 · Sep 30, 2024 −$224.59M
Net Income Q3 2025 · Jun 30, 2024 −$68.06M
Net Income Q3 2025 · Mar 31, 2024 −$72.4M
Operating Income Q3 2025 · Sep 30, 2025 −$57.43M
Operating Income Q3 2025 · Sep 30, 2025 −$210.54M
Operating Income Q3 2025 · Sep 30, 2024 −$89.58M
Operating Income Q3 2025 · Sep 30, 2024 −$243.31M
Revenue Q3 2025 · Sep 30, 2025 $45.87M
Revenue Q3 2025 · Sep 30, 2025 $103.62M
Revenue Q3 2025 · Sep 30, 2024 $12.5M
Revenue Q3 2025 · Sep 30, 2024 $16M